Johannes Schüller

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Richard Herrmann, G. Bodoky, Thomas Ruhstaller et al. · Journal of Clinical Oncology · 2007 · 591 citations

Medicine, Oncology, Pharmacology +15

Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001

Jürg Bernhard, Daniel Dietrich, Werner Scheithauer et al. · Journal of Clinical Oncology · 2008 · 101 citations · Full text

Medicine, Oncology, Pharmacology +15

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results

Heinz Ludwig, Amos Cohen, H. Huber et al. · European Journal of Cancer and Clinical Oncology · 1991 · 25 citations

Medicine, Hematology, Pharmacotherapy +14